Myasthenia Gravis and its Association With Thyroid Diseases
Open Access
- 4 September 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cureus
- Vol. 12 (9)
- https://doi.org/10.7759/cureus.10248
Abstract
Myasthenia gravis (MG) is a rare autoimmune neuromuscular junction disorder, and thyroid disorder is a disorder involving the thyroid receptor, of which Graves' disease (GD) is the most common autoimmune thyroid disorder, in which antibodies develop against thyroid receptors. Both may have similar clinical features. In myasthenia gravis, autoimmune antibodies develop against postsynaptic neuromuscular junction disrupting the neuromuscular transmission, resulting in fluctuating muscle weakness and fatigue. It is a disease of young women and older men. The two pathologies may coexist in a patient or can precede one another. Graves' disease (GD) among thyroid diseases is most often associated with MG. Similarities in clinical features lead to difficulty in distinguishing MG and GD. Despite the standard treatment of myasthenia gravis, including steroids, acetylcholinesterases, rituximab, immunosuppressants, and thymectomy, there is still an increased number of relapses and myasthenia crisis. Eculizumab and plasmapheresis are the two new treatment options for MG, with supporting evidence of marked improvement in recent studies. Myasthenia gravis and Graves' disease have a see-saw relationship. Treating one pathology may worsen the other, so physicians should always consider MG as a differential in patients of hyperthyroidism presenting with new symptoms of fatigue or respiratory failure or neuromuscular weakness. In this comprehensive review article, we tried to establish an association between myasthenia gravis and Graves' disease (GD) by exploring currently available literature from PubMed. However, more studies need to be done to establish an association between pathologies.Keywords
This publication has 38 references indexed in Scilit:
- Autoimmune thyroid disordersAutoimmunity Reviews, 2015
- Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysisZeitschrift für Neurologie, 2014
- Diagnostic and clinical classification of autoimmune myasthenia gravisJournal of Autoimmunity, 2014
- Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitalsNeurology, 2009
- Concurrent Graves disease thyrotoxicosis and myasthenia gravis: the treatment of the former may dangerously reveal the latterAnaesthesia, 2008
- Therapeutic options in autoimmune myasthenia gravisAutoimmunity Reviews, 2007
- Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid diseaseActa Neurologica Scandinavica, 2006
- Myasthenia gravis with thymoma associated with occult thyroid carcinomaSurgery Today, 1992
- A Case Report of Myasthenia Gravis Associated with Hashimoto's ThyroiditisPsychiatry and Clinical Neurosciences, 1981
- Myasthenia Gravis, Pernicious Anemia, and Hashimoto's ThyroiditisArchives of Neurology, 1979